Produodopa is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
The PAI was conducted for two drug product applications (ANDAs) filed from this facility
Pimavanserin is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
The certification underscores Venus Remedies Limited's adherence to stringent quality control measures
The company has posted net profit of Rs.33.57 crores for the 9 Months period ended December 31, 2023
Automated parallel capillary electrophoresis system simplifies protein analysis
Subscribe To Our Newsletter & Stay Updated
